Brookstone Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4M | Buy |
115,415
+2,454
| +2% | +$264K | 0.16% | 153 |
|
|
2025
Q1 | $11.4M | Buy |
112,961
+7,101
| +7% | +$716K | 0.16% | 155 |
|
|
2024
Q4 | $9.46M | Buy |
105,860
+20,307
| +24% | +$1.81M | 0.14% | 184 |
|
|
2024
Q3 | $7.17M | Buy |
85,553
+15,608
| +22% | +$1.31M | 0.11% | 203 |
|
|
2024
Q2 | $5.41M | Buy |
69,945
+55,645
| +389% | +$4.31M | 0.09% | 219 |
|
|
2024
Q1 | $979K | Buy |
14,300
+3,710
| +35% | +$254K | 0.02% | 495 |
|
|
2023
Q4 | $612K | Sell |
10,590
-129
| -1% | -$7.46K | 0.01% | 557 |
|
|
2023
Q3 | $542K | Buy |
10,719
+134
| +1% | +$6.77K | 0.01% | 552 |
|
|
2023
Q2 | $553K | Sell |
10,585
-20,832
| -66% | -$1.09M | 0.01% | 557 |
|
|
2023
Q1 | $1.63M | Buy |
31,417
+20,685
| +193% | +$1.07M | 0.03% | 357 |
|
|
2022
Q4 | $497K | Buy |
10,732
+4
| +0% | +$185 | 0.01% | 578 |
|
|
2022
Q3 | $425K | Buy |
+10,728
| New | +$425K | 0.01% | 591 |
|
|
2015
Q4 | – | Sell |
-77
| Closed | -$1K | – | 240 |
|
|
2015
Q3 | $1K | Hold |
77
| – | – | ﹤0.01% | 1783 |
|
|
2015
Q2 | $1K | Buy |
+77
| New | +$1K | ﹤0.01% | 1934 |
|